DXB 5.62% 42.0¢ dimerix limited

Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-219

  1. BI
    201 Posts.
    lightbulb Created with Sketch. 25
    People overrated and sold. Results are still very good. There’s plenty of irons in the fire for this company. Buyers will be flocking back for bargains
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.